// App-Quantinova.ai

2899 : Mitophagy imparts enzalutamide resistance in prostate cancer

Researchers

Presenter

  • Hirak S. Basu

Principal Investigators

  • Cynthia L. Schrieber

  • Jamie M. Sperger

  • Maryanne Naundorf

  • Ashley M. Weichman

  • Farideh Mehraein-Ghomi

  • Dawn R. Church

  • Joshua M. Lang

  • George Wilding

Medical Centers

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • C-C Motif Chemokine Ligand 22

  • Circulating tumor cells

Drug/Treatment

  • CB-7598

  • Enzalutamide

  • Androgen Tear

  • Zytiga

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved